Patents Assigned to Gen Pharma Holdings LLC
  • CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
    Publication number: 20170319550
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polmyer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: March 20, 2017
    Publication date: November 9, 2017
    Applicant: GEN PHARMA HOLDINGS, LLC
    Inventor: Sunil GUPTA
  • CAI-based systems and methods for the localized treatment of uveitis
    Patent number: 9629826
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: April 25, 2017
    Assignee: GEN PHARMA HOLDINGS, LLC
    Inventor: Sunil Gupta
  • CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
    Publication number: 20160106717
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: October 15, 2015
    Publication date: April 21, 2016
    Applicant: Gen Pharma Holdings LLC
    Inventor: Sunil Gupta
  • CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
    Publication number: 20160106718
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 21, 2016
    Applicant: Gen Pharma Holdings LLC
    Inventor: Sunil GUPTA